Obesity is a complex metabolic disorder, with several licensed drug and surgical therapies currently available.

Current therapies are often associated with inadequate efficacy or complications and side effects, limiting their use.

Multiple pathophysiological mechanisms of obesity are recognized, though only few of these are manipulated using currently licensed therapies.

Whilst most drug classes are in early stages of development and/or clinical trials, results are promising for multiple drug targets.